NEW YORK, Oct. 25 (GenomeWeb News) - Ingenuity Systems will license its pathway analysis software to Genizon BioSciences, the companies announced today.

 

Under the agreement, Genizon will apply Ingenuity Pathways Analysis 3.0 to its lead programs studying Crohn's disease, psoriasis, asthma, baldness, and schizophrenia.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.